CareCloud Increases 2025 Revenue Guidance Following Medsphere Acquisition
CareCloud (NASDAQ: CCLD) has raised its 2025 revenue guidance following the acquisition of Medsphere Systems Corporation's business assets. The company now projects 2025 revenue of $116-118 million, up from the previous guidance of $111-114 million. For 2026, CareCloud anticipates revenue of $128-130 million.
The improved outlook reflects increased scale and expanded participation in the hospital IT market, with growth driven by cross-selling opportunities, expanded hospital adoption, and continued AI innovation. While Adjusted EBITDA guidance remains unchanged, GAAP EPS will be impacted by higher non-cash amortization expense from the acquisition.
CareCloud (NASDAQ: CCLD) ha alzato le previsioni di ricavi per il 2025 dopo l'acquisizione dei beni aziendali di Medsphere Systems Corporation. Ora stima ricavi 2025 tra 116 e 118 milioni di dollari, rispetto alla guida precedente di 111-114 milioni. Per il 2026 prevede ricavi di 128-130 milioni di dollari.
Le prospettive migliorate riflettono una maggiore scala e una partecipazione ampliata nel mercato IT ospedaliero, con la crescita trainata da opportunità di cross-selling, maggiore adozione da parte degli ospedali e continua innovazione nell'IA. La guidance sull'Adjusted EBITDA rimane invariata, mentre l'EPS secondo i principi contabili GAAP sarà influenzato da maggiori oneri di ammortamento non monetari derivanti dall'acquisizione.
CareCloud (NASDAQ: CCLD) ha elevado su previsión de ingresos para 2025 tras la adquisición de los activos comerciales de Medsphere Systems Corporation. Ahora proyecta ingresos de 2025 de 116-118 millones de dólares, frente a la guía anterior de 111-114 millones. Para 2026 espera ingresos de 128-130 millones de dólares.
La perspectiva mejorada refleja mayor escala y una mayor participación en el mercado de TI hospitalaria, con crecimiento impulsado por oportunidades de cross-selling, mayor adopción por parte de hospitales y la continuada innovación en IA. La guía de EBITDA ajustado no cambia, pero el BPA GAAP se verá afectado por un mayor gasto por amortización no monetaria derivado de la adquisición.
CareCloud (NASDAQ: CCLD)는 Medsphere Systems Corporation의 영업 자산 인수 이후 2025년 매출 전망을 상향 조정했습니다. 이제 2025년 매출을 1억1600만~1억1800만 달러로 예상하며, 이전 가이드인 1억1100만~1억1400만 달러에서 상향되었습니다. 2026년 매출은 1억2800만~1억3000만 달러로 전망합니다.
전망 개선은 규모 확대 및 병원 IT 시장 참여 증가를 반영하며, 크로스셀링 기회, 병원 채택 확대, 지속적인 AI 혁신이 성장 동력입니다. 조정 EBITDA 가이던스는 변함없지만, 인수로 인한 비현금성 상각비 증가로 GAAP 기준 주당순이익(EPS)은 영향을 받을 것입니다.
CareCloud (NASDAQ: CCLD) a relevé ses prévisions de chiffre d'affaires 2025 après l'acquisition des actifs commerciaux de Medsphere Systems Corporation. La société prévoit désormais des revenus 2025 de 116 à 118 millions de dollars, contre 111–114 millions auparavant. Pour 2026, CareCloud anticipe des revenus de 128–130 millions de dollars.
Cette perspective améliorée reflète une plus grande envergure et une participation accrue sur le marché des technologies de l'information hospitalières, la croissance étant portée par des opportunités de vente croisée, une adoption élargie par les hôpitaux et une innovation continue en IA. Les prévisions d'EBITDA ajusté restent inchangées, mais le BPA selon les normes GAAP sera affecté par une hausse des charges d'amortissement non monétaires liées à l'acquisition.
CareCloud (NASDAQ: CCLD) hat aufgrund der Übernahme der Geschäftsvermögenswerte von Medsphere Systems Corporation seine Umsatzprognose für 2025 angehoben. Das Unternehmen rechnet nun mit Umsätzen in 2025 von 116–118 Mio. USD, zuvor wurden 111–114 Mio. USD prognostiziert. Für 2026 erwartet CareCloud Umsätze von 128–130 Mio. USD.
Der verbesserte Ausblick spiegelt eine größere Skalierung und eine erweiterte Präsenz im Krankenhaus-IT-Markt wider; das Wachstum wird durch Cross-Selling-Möglichkeiten, verstärkte Krankenhausakzeptanz und fortgesetzte KI-Innovationen getragen. Die Prognose für das bereinigte EBITDA bleibt unverändert, während das GAAP-Ergebnis je Aktie durch höhere nicht zahlungswirksame Abschreibungen aus der Übernahme belastet wird.
- Increased 2025 revenue guidance by approximately $4-5 million
- Projected 2026 revenue growth to $128-130 million
- Expanded market presence through Medsphere acquisition
- Cross-selling opportunities and expanded hospital adoption potential
- Continued investment in AI innovation and automation
- Higher non-cash amortization expense will impact GAAP EPS
- Integration costs and challenges from Medsphere acquisition
Insights
CareCloud's Medsphere acquisition boosts 2025 revenue forecast by ~4.5%, signaling strong growth trajectory and expanded market reach.
CareCloud's upward revision of its
The revenue increase without a corresponding adjustment to Adjusted EBITDA guidance suggests potential integration costs or operational investments that may temporarily offset revenue gains. CareCloud's acknowledgment that GAAP EPS will be affected by higher non-cash amortization expense is typical of acquisition accounting, as the company must amortize the acquired intangible assets over time.
Strategically, this acquisition represents a significant market expansion for CareCloud, extending their reach from their traditional ambulatory care focus into the broader hospital IT market. This diversification could reduce market concentration risk while creating cross-selling opportunities across their now-expanded customer base. The emphasis on their AI Center of Excellence signals that CareCloud views technological innovation as central to their competitive advantage, particularly in automating revenue cycle management – a critical but traditionally labor-intensive area of healthcare operations.
With healthcare facilities facing persistent staffing challenges and margin pressures, CareCloud's focus on efficiency through AI-powered solutions addresses real market needs while potentially creating recurring revenue streams from their expanded technology portfolio.
Company Raises 2025 Revenue Outlook to
SOMERSET, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (NASDAQ: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and AI-powered solutions for hospitals and medical practices nationwide, today announced updated financial guidance following the August 22, 2025 closing of its acquisition of the business assets of Medsphere Systems Corporation (“Medsphere”).
For the full year 2025, CareCloud now expects revenue in the range of
“This increase in revenue guidance underscores the strong momentum generated by our transformative acquisition of Medsphere and the market demand we are seeing across our expanded product portfolio,” said Stephen Snyder, Co-Chief Executive Officer of CareCloud. “We are excited by the opportunities ahead as we bring CareCloud’s AI-driven solutions to both ambulatory and inpatient providers nationwide.”
“Our AI Center of Excellence is rapidly advancing tools that automate revenue cycle workflows and support clinicians in real time,” said A. Hadi Chaudhry, Co-Chief Executive Officer of CareCloud. “These innovations are designed to improve efficiency, strengthen financial performance, and enhance patient outcomes across the care continuum.”
About CareCloud
CareCloud brings disciplined innovation to the business of healthcare. Our suite of AI and technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care, while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health, at carecloud.com.
Follow CareCloud on LinkedIn, X and Facebook.
For additional information, please visit our website at carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com.
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could”, “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, and the expected results from the integration of our acquisitions. Past operational or stock price performance is not an indication of future performance.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
SOURCE: CareCloud
Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com
Investor Contact:
Stephen Snyder
Co-Chief Executive Officer
CareCloud, Inc.
ir@carecloud.com
FAQ
What is CareCloud's new revenue guidance for 2025 after the Medsphere acquisition?
How much revenue does CareCloud expect to generate in 2026?
Will the Medsphere acquisition affect CareCloud's EBITDA and EPS?
What are the main growth drivers for CareCloud following the Medsphere acquisition?
When did CareCloud complete the Medsphere acquisition?
